Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled trial of Huoxia Ganmao Keli for the common cold
CTR20253793Phase 3Active
- Sponsor
- Yiling Pharmaceutical
- Start
- Oct 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of huoxia ganmao keli in nasopharyngitis, sponsored by Yiling Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
huoxia ganmao keli
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20253793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253793.